Vulvodynia Clinical Trials

Find Vulvodynia Clinical Trials Near You

Examining the Efficacy of a Multimodal Virtual Program on Pain and Sexual Outcomes in Individuals With Provoked Vestibulodynia: A Randomized Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if a 3-month online pelvic health program works to improve pain and sexual wellbeing in adult women with chronic genital pain. The main research questions it aims to answer are: * How well does the program work to improve pain and sexual wellbeing? * How well does the program work to improve pain anxiety and pain interference? * How do participants rate their improvement after completing the program? * How satisfied are participants with the program? Researchers will compare participants who receive the program right away to those who wait for the program. Participants who receive the program right away will * Progress through the program at their own pace * Learn about pain science, do pelvic health exercises, and use information to be more mindful and less anxious about the pain * Answer questions about their pain experiences and sexual wellbeing before and after the 3-month program, as well as 3 months after the end of the program * Provide information about their experiences with the program and progress through the program during and after the program

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Self-reported physician diagnosis of provoked vestibulodynia (PVD)

• PVD duration of at least 3 months

• PVD pain intensity rating of at least 3 on a scale from 0 (no pain) to 10 (extreme pain)

• Resides in North America (Canada or the United States)

• Fluent in English

Locations
Other Locations
Canada
Sexual Health Research Laboratory
RECRUITING
Kingston
Contact Information
Primary
Shannon Research Coordinator, MA
qshrl@queensu.ca
613 533 3276
Backup
Marilyn Post-doctoral fellow, PhD
qshrl@queensu.ca
613 533 3276
Time Frame
Start Date: 2025-12-17
Estimated Completion Date: 2028-12
Participants
Target number of participants: 250
Treatments
Experimental: Active treatment
Participants in the active treatment arm will receive access to the program once determined eligible.
No_intervention: Waitlist control
Participants in the waitlist control group will wait 3 months for access to the program. As the wait, they will receive the same surveys at the same timepoints as the active treatment group.
Related Therapeutic Areas
Sponsors
Leads: Queen's University

This content was sourced from clinicaltrials.gov